Priya N. Werahera, PhD, presented “Next Generation Sequencing of Microbiomes in Urine Samples of Prostate Cancer Patients” during the 30th Annual International Prostate Cancer Update on January 23rd, 2020 in Beaver Creek, Colorado.
How to cite: Werahera, Priya N. “Next Generation Sequencing of Microbiomes in Urine Samples of Prostate Cancer Patients” January 23rd, 2020. Accessed Oct 2020. https://grandroundsinurology.com/next-generation-sequencing-of-microbiomes-in-urine-samples-of-prostate-cancer-patients/
Next Generation Sequencing of Microbiomes in Urine Samples of Prostate Cancer Patients – Summary:
Priya N. Werahera, PhD, Associate Professor in the Departments of Pathology and Bioengineering at the University of Colorado Anschutz Medical Campus, discusses the presence of bacteria in the prostrate and that next generation sequencing is the best way to identify microbial DNA in post DRE urine samples. He reveals that cutibacterium acnes strain Type II is the most prevalent bacteria found in PCa patients. Finegoldia magna produces equol and is associated with lower risks of prostate cancer. It is still unclear whether a malignant tumor creates an ideal environment for infection, or if a bacterial infection precedes a carcinoma.
About The 30th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. Dr. Werahera delivered this educational activity during the 30th iteration of the meeting in January 2020.
For further educational activities from this conference, visit our collection page.